155 related articles for article (PubMed ID: 38745177)
1. Prediction of carbapenem-resistant gram-negative bacterial bloodstream infection in intensive care unit based on machine learning.
Liang Q; Ding S; Chen J; Chen X; Xu Y; Xu Z; Huang M
BMC Med Inform Decis Mak; 2024 May; 24(1):123. PubMed ID: 38745177
[TBL] [Abstract][Full Text] [Related]
2. Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
Andria N; Henig O; Kotler O; Domchenko A; Oren I; Zuckerman T; Ofran Y; Fraser D; Paul M
J Antimicrob Chemother; 2015 Nov; 70(11):3146-53. PubMed ID: 26209312
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection.
Qu J; Feng C; Li H; Lv X
Int J Antimicrob Agents; 2021 Mar; 57(3):106284. PubMed ID: 33484833
[TBL] [Abstract][Full Text] [Related]
4. Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care.
Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Karapanagiotou A; Karyoti A; Gritsi-Gerogianni N; Tsakris A; Roilides E
J Hosp Infect; 2018 Aug; 99(4):396-404. PubMed ID: 29792971
[TBL] [Abstract][Full Text] [Related]
5. Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study.
Liang Q; Chen J; Xu Y; Chen Y; Huang M
Antimicrob Resist Infect Control; 2022 Jun; 11(1):89. PubMed ID: 35733230
[TBL] [Abstract][Full Text] [Related]
6. Early prediction of carbapenem-resistant Gram-negative bacterial carriage in intensive care units using machine learning.
Liang Q; Zhao Q; Xu X; Zhou Y; Huang M
J Glob Antimicrob Resist; 2022 Jun; 29():225-231. PubMed ID: 35351674
[TBL] [Abstract][Full Text] [Related]
7. Effects of an Active Surveillance Program and Enhanced Infection Control Measures on Carbapenem-Resistant Gram-Negative Bacterial Carriage and Infections in Pediatric Intensive Care.
Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Volakli E; Karyoti A; Sdougka M; Tsakris A; Roilides E
Microb Drug Resist; 2019 Nov; 25(9):1347-1356. PubMed ID: 31364923
[TBL] [Abstract][Full Text] [Related]
8. A Longitudinal Study of Spontaneous Gut Decolonization of Carbapenem-resistant Gram-negative Bacteria in Neonatal and Pediatric Patients.
Darda VM; Iosifidis E; Antachopoulos C; Kirvasilis F; Zarras C; Simitsopoulou M; Papakonstantinou E; Agakidou E; Sdougka M; Roilides E
Pediatr Infect Dis J; 2022 Aug; 41(8):648-653. PubMed ID: 35446811
[TBL] [Abstract][Full Text] [Related]
9. Changing Epidemiology and Decreased Mortality Associated With Carbapenem-resistant Gram-negative Bacteria, 2000-2017.
Babiker A; Clarke LG; Saul M; Gealey JA; Clancy CJ; Nguyen MH; Shields RK
Clin Infect Dis; 2021 Dec; 73(11):e4521-e4530. PubMed ID: 32990319
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, antimicrobial resistance, and mortality risk factors of carbapenem resistant gram-negative bacteria in hematopoietic stem cell transplantation recipients.
Jia Y; Li Y; Liu Y; Yang Z; Chen X; Liu Y
Front Cell Infect Microbiol; 2022; 12():1098856. PubMed ID: 36710978
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of tigecycline in the treatment of infections caused by carbapenem-resistant gram-negative bacteria in pediatric liver transplant recipients: A retrospective study.
Chen F; Shen C; Pang X; Zhang Z; Deng Y; Han L; Chen X; Zhang J; Xia Q; Qian Y
Transpl Infect Dis; 2020 Feb; 22(1):e13199. PubMed ID: 31627248
[TBL] [Abstract][Full Text] [Related]
12. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study.
Gao S; Yan R; Zhang S; Li L; Zhang R; Fan J; Qin J; Peng Y; Wan D; Cao W; Bian Z
J Glob Antimicrob Resist; 2024 Mar; 36():96-104. PubMed ID: 38128727
[TBL] [Abstract][Full Text] [Related]
13. Forecasting models of infections due to carbapenem-resistant Gram-negative bacteria in an intensive care unit in an endemic area.
Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Mouloudi E; Karyoti A; Tsakris A; Roilides E
J Glob Antimicrob Resist; 2020 Mar; 20():214-218. PubMed ID: 31265930
[TBL] [Abstract][Full Text] [Related]
14. A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria.
Ferrer R; Soriano A; Cantón R; Del Pozo JL; García-Vidal C; Garnacho-Montero J; Larrosa N; Rascado P; Salavert M; Pintado V; Giró-Perafita N; Badia X
Rev Esp Quimioter; 2022 Oct; 35(5):455-467. PubMed ID: 35859521
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Bassetti M; Echols R; Matsunaga Y; Ariyasu M; Doi Y; Ferrer R; Lodise TP; Naas T; Niki Y; Paterson DL; Portsmouth S; Torre-Cisneros J; Toyoizumi K; Wunderink RG; Nagata TD
Lancet Infect Dis; 2021 Feb; 21(2):226-240. PubMed ID: 33058795
[TBL] [Abstract][Full Text] [Related]
16. Effect on 30-day mortality and duration of hospitalization of empirical antibiotic therapy in CRGNB-infected pneumonia.
Li R; Tang H; Xu H; Cui K; Li S; Shen J
Ann Clin Microbiol Antimicrob; 2021 Mar; 20(1):15. PubMed ID: 33678191
[TBL] [Abstract][Full Text] [Related]
17. Predicting acquisition of carbapenem-resistant Gram-negative pathogens in intensive care units.
Dantas LF; Dalmas B; Andrade RM; Hamacher S; Bozza FA
J Hosp Infect; 2019 Oct; 103(2):121-127. PubMed ID: 31039381
[TBL] [Abstract][Full Text] [Related]
18. [Impact of an active surveillance program and infection control measures on the incidence of carbapenem-resistant gram-negative bacilli in an intensive care unit].
Vargas JM; Moreno Mochi MP; López CG; Alarcón JA; Acosta N; Soria K; Nuñez JM; Villafañe S; Ramacciotti J; Del Campo R; Jure MA
Rev Argent Microbiol; 2022; 54(2):134-142. PubMed ID: 34088536
[TBL] [Abstract][Full Text] [Related]
19. Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study.
Hu Y; Li D; Zhang G; Dai Y; Chen M; Jiang H; Cui W
Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):875-884. PubMed ID: 38443737
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea.
Kim T; Chong YP; Park SY; Jeon MH; Choo EJ; Chung JW; Lee HK; Moon C; Kim DM; Peck KR; Kim YS
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):457-61. PubMed ID: 24462178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
